Physician profile
Jill E Vollbrecht
NPI 1013130525
$986.59
in general payments reported to CMS, 2019-2025
15 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $19.90 · 2022: $171 · 2023: $166 · 2024: $151 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453 · Long Term Medical Supply Or Device Loan: $99.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.42 |
| Long Term Medical Supply Or Device Loan | $99.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $286.30 | 2019-2025 | Freestyle Insulinx |
| Tandem Diabetes Care, INC. | $237.30 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $101.72 | 2022-2025 | Ozempic, Rybelsus |
| Amgen INC. | $52.28 | 2022-2025 | Tepezza |
| Ascensia Diabetes Care US INC. | $47.70 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $41.55 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.25 | 2022-2023 | |
| Medtronic Vascular, INC. | $28.39 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.10 | 2022 | |
| Sanofi-Aventis U.S. LLC | $27.31 | 2023 | |
| Merck Sharp & Dohme LLC | $26.23 | 2022-2023 | Gardasil 9, Vaxneuvance |
| Exact Sciences Corporation | $23.59 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $21.48 | 2025 | |
| Lilly USA, LLC | $19.06 | 2022 | |
| Abbvie INC. | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Vollbrecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.